ENTO

8-K - GridAI Technologies Corp. (0001604191) (Filer)

BOCA RATON, FL / ACCESS Newswire / November 28, 2025 / Entero Therapeutics, Inc. (NASDAQ:ENTO) (the "Company") today announced that it will change its name to GridAI Technologies Corp., effective at 12:01 Eastern Time on Monday, December 1, 2025. The name change closely aligns the Company's business following its acquisition of 100% of GRID AI Corp ("GRID AI"), a grid-edge, AI-driven software and controls platform that enables utilities, retail energy providers, and large power users to dynamically manage load and distributed energy resources including battery energy storage systems. In connection with the name change, the Company will change its ticker symbol to "GRDX". The Company's common

10-Q - Entero Therapeutics, Inc. (0001604191) (Filer)

BOCA RATON, FLORIDA / ACCESS Newswire / November 19, 2025 / Entero Therapeutics, Inc. (NASDAQ:ENTO) ("Entero" or the "Company") today announced that its subsidiary Grid AI has executed a Letter of Intent (LOI) with a stealth-mode hyperscaler artificial intelligence (AI) data-center developer to deploy Grid AI's advanced power-cluster optimization and orchestration platform at the customer's first large-scale AI campus. The campus-expected to be among the more sophisticated AI-ready digital-infrastructure sites in development-will be located in the ERCOT market in Texas.The LOI represents Grid AI's first hyperscaler agreement and marks a major milestone in Entero's strategy to build the leadi

NT 10-Q - Entero Therapeutics, Inc. (0001604191) (Filer)

SCHEDULE 13G - Entero Therapeutics, Inc. (0001604191) (Subject)

Timed with a sharp acceleration in AI-data-center expansion, with more than $60B in new projects announced in the last 90 days. BOCA RATON, FL / ACCESS Newswire / November 13, 2025 / Entero Therapeutics, Inc. (NASDAQ:ENTO) ("Entero" or the "Company") today announced that its wholly owned subsidiary, Grid AI, is finalizing the establishment of a U.S.-based leadership team composed of highly accomplished executives from the energy, power, and technology sectors. This marks a significant step in Grid AI's expansion into the rapidly growing U.S. market for AI-ready digital infrastructure and orchestration technology.Entero expects to announce the appointment of a U.S.-based Chief Executive Offic

8-K - Entero Therapeutics, Inc. (0001604191) (Filer)

Integration boosts Grid AI's deployment capacity as AI data-center power demand approaches 50 GW, growing by over 165% through 2030i BOCA RATON, FL / ACCESS Newswire / November 6, 2025 / Entero Therapeutics, Inc. (NASDAQ:ENTO) ("ENTO" or the "Company"), the parent company of Grid AI, announced today the signing of a Letter of Intent to integrate the LV Grid engineering team and related intellectual property into Grid AI.The company believes the addition of LV Grid marks a critical step in Grid AI's strategy to capture a leading position in the rapidly expanding AI data-center energy-orchestration market. Under the proposed structure, LV Grid's team, recognized for its deep experience in cont

8-K - Entero Therapeutics, Inc. (0001604191) (Filer)

BOCA RATON, FL / ACCESS Newswire / October 30, 2025 / Entero Therapeutics (NASDAQ:ENTO) has just made one of the boldest moves in its history, a reinvention that trades long biotech timelines for immediate impact. By acquiring GRID AI, Entero has vaulted straight into the nexus of two of the decade's biggest themes: the surge in AI-driven energy demand and the transformation of the grid to handle it. The acquisition also facilitated the company's return to full compliance with Nasdaq listing requirements, marking not just a strategic but also a structural milestone.Don't treat this pivot as a cautious hedge. It is a full-tilt bet on scarcity, scale, and timing - the ingredients that all stak

BOCA RATON, FL / ACCESS Newswire / October 30, 2025 / Entero Therapeutics, Inc. ("Entero" or the "Company") (NASDAQ:ENTO) is pleased to announce that, as a result of the acquisition of 100% of Grid AI Corp. ("Grid AI"), it has regained compliance with Nasdaq Listing Rule 5550(b)(1) (the "Equity Rule").Entero's publicly‑listed platform now sits at the intersection of AI, data centers, power grids, and global infrastructure. The acquisition of Grid AI, now operating as a wholly‑owned subsidiary of Entero, enables the Company to participate in one of the most significant secular growth arenas of the coming decade: hyperscale data centers, grid‑edge orchestration, and AI‑driven infrastructure op

8-K - Entero Therapeutics, Inc. (0001604191) (Filer)

BOCA RATON, FL / ACCESS Newswire / October 16, 2025 / Entero Therapeutics, Inc. (NASDAQ:ENTO) ("ENTO" or the "Company") a company pioneering innovation at the intersection of biotechnology and AI-driven energy infrastructure launches Grid AI Corp., to redefine how artificial intelligence infrastructure connects to the power grid.According to the company, the rise of artificial intelligence is driving the fastest infrastructure build-out in modern history and power is the new bottleneck. Over the next decade, global data center electricity demand is projected to exceed 1,000 terawatt-hours annually, with AI workloads alone representing over 30% of that growth. Analysts now estimate that more

BOCA RATON, FL, NY / ACCESS Newswire / October 14, 2025 / Entero Therapeutics (NASDAQ:ENTO) has reinvented itself in a way few public companies dare. By acquiring GRID AI, it has stepped directly into one of the most urgent races of the decade: making sure energy can keep pace with the accelerating appetite of artificial intelligence. The Entero story is now less about enzymes and long clinical trials. It is now about electricity, orchestration, and scale.Which could happen quickly, considering that GRID AI is no tech-sector rookie. More than fifty million dollars and years of engineering have gone into building a platform designed for this very moment. Its purpose is simple but vital: orche

BOCA RATON, FL / ACCESS Newswire / October 14, 2025 / Entero Therapeutics (NASDAQ:ENTO) didn't tiptoe into reinvention. It jumped. The company, once known for enzymes and patient trials, is now in the grid game, acquiring GRID AI in a deal that rewires its entire identity. That may sound dramatic, but reinvention usually is. Investors who only saw a challenged biotech woke up to find the ticker transformed into a player in one of the most valuable races of the decade: making sure the power keeps flowing in an AI-driven world.GRID AI isn't some shiny toy pulled off a venture shelf. It is a platform that has already absorbed over $50 million in investment since 2019. Its calling card is contro

8-K - Entero Therapeutics, Inc. (0001604191) (Filer)

Transaction positions ENTO in the high-growth AI energy-infrastructure market, amid a surge of multi-billion-dollar hyperscaler spending on data centers, and rapid growth in behind-the-meter energy storage solutions BOCA RATON, FL / ACCESS Newswire / October 1, 2025 / Entero Therapeutics, Inc. (NASDAQ:ENTO) ("ENTO" or the "Company") today announced it has acquired 100% of GRID AI Corp ("GRID AI"), a grid-edge, AI-driven software and device platform that enables utilities, retailers, and large power users to dynamically manage load and distributed energy resources ("DERs").Over $50 million has been invested since 2019 to commercialize this revolutionary autonomous platform delivering Dynamic

SEC STAFF ACTION - Entero Therapeutics, Inc. (0001604191) (Filer)

EFFECT - Entero Therapeutics, Inc. (0001604191) (Filer)

8-K - Entero Therapeutics, Inc. (0001604191) (Filer)

S-1/A - Entero Therapeutics, Inc. (0001604191) (Filer)

8-K - Entero Therapeutics, Inc. (0001604191) (Filer)

S-1 - Entero Therapeutics, Inc. (0001604191) (Filer)

PRE 14A - Entero Therapeutics, Inc. (0001604191) (Filer)